Pharmacists step in to fight dangerous drug side effects
NCT ID NCT07446218
Summary
This study tests whether having pharmacists provide education and monitoring can help control weight gain and other metabolic side effects caused by newer antipsychotic medications. It will involve 148 adults in Pakistan who are starting these medications for conditions like schizophrenia or bipolar disorder. Participants will either receive standard care or standard care plus regular check-ins with a pharmacist focused on lifestyle and medication guidance over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Punjab Institute of Mental Health
Lahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The University of Lahore
Lahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.